Haleos Labs schedules board meeting for May 29
Haleos Labs Limited has called a board meeting for May 29, 2026, to approve the financial results for FY26 under Regulation 29.

*this image is generated using AI for illustrative purposes only.
Haleos Labs Limited has scheduled a board meeting to discuss its financial performance for the upcoming fiscal period. The meeting is set to take place on May 29, 2026.
Agenda for the Meeting
The primary purpose of the meeting is to consider and approve the financial results for FY26. This proceeding is conducted in accordance with the requirements of Regulation 29.
Regulatory Compliance
The intimation of this meeting aligns with the company's commitment to maintaining transparency with its shareholders and regulatory bodies. The board will review the necessary financial statements and documentation required for the period ending March 31, 2026.
Historical Stock Returns for Haleos
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.26% | +9.28% | +19.58% | +20.26% | +22.03% | +176.94% |
How might Haleos Labs Limited's FY26 financial results compare to industry peers, and what key performance metrics will investors be watching most closely?
Will the board meeting on May 29, 2026 also address any dividend announcements or capital allocation strategies alongside the FY26 results?
What potential strategic initiatives or business expansions could Haleos Labs Limited announce following the approval of its FY26 financial results?


































